FEORX | VTSNX | FEORX / VTSNX | |
Total Expense Ratio | 0.80 | 0.06 | 1,333% |
Annual Report Gross Expense Ratio | 0.80 | 0.06 | 1,333% |
Fund Existence | 8 years | 15 years | - |
Gain YTD | 23.671 | 21.552 | 110% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.3B | 506B | 3% |
Annual Yield % from dividends | 4.89 | 2.85 | 172% |
Returns for 1 year | 15.57 | 16.43 | 95% |
Returns for 3 years | 39.81 | 38.67 | 103% |
Returns for 5 years | 41.46 | 39.95 | 104% |
Returns for 10 years | N/A | 67.52 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MCI | 20.75 | 0.29 | +1.42% |
Barings Corporate Investors | |||
FFLV | 22.63 | 0.09 | +0.41% |
Fidelity Fundamental Large Cap Value ETF | |||
VIXM | 16.65 | 0.01 | +0.06% |
ProShares VIX Mid-Term Futures | |||
FCOM | 66.87 | -0.65 | -0.96% |
Fidelity MSCI Communication ServicesETF | |||
THNR | 22.80 | -0.28 | -1.22% |
Amplify Weight Loss Drug & Treatment ETF |